Literature DB >> 11146273

Development of a comorbidity index using physician claims data.

C N Klabunde1, A L Potosky, J M Legler, J L Warren.   

Abstract

Important comorbidities recorded on outpatient claims in administrative datasets may be missed in analyses when only inpatient care is considered. Using the comorbid conditions identified by Charlson and colleagues, we developed a comorbidity index that incorporates the diagnostic and procedure data contained in Medicare physician (Part B) claims. In the national cohorts of elderly prostate (n = 28,868) and breast cancer (n = 14,943) patients assessed in this study, less than 10% of patients had comorbid conditions identified when only Medicare hospital (Part A) claims were examined. By incorporating physician claims, the proportion of patients with comorbid conditions increased to 25%. The new physician claims comorbidity index significantly contributes to models of 2-year noncancer mortality and treatment received in both patient cohorts. We demonstrate the utility of a disease-specific index using an alternative method of construction employing study-specific weights. The physician claims index can be used in conjunction with a comorbidity index derived from inpatient hospital claims, or employed as a stand-alone measure.

Entities:  

Mesh:

Year:  2000        PMID: 11146273     DOI: 10.1016/s0895-4356(00)00256-0

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  847 in total

1.  Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.

Authors:  Hanna K Sanoff; William R Carpenter; Til Stürmer; Richard M Goldberg; Christopher F Martin; Jason P Fine; Nadine Jackson McCleary; Jeffrey A Meyerhardt; Joyce Niland; Katherine L Kahn; Maria J Schymura; Deborah Schrag
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancer.

Authors:  Ami Vyas; Suresh Madhavan; Usha Sambamoorthi
Journal:  Breast Cancer Res Treat       Date:  2014-11-16       Impact factor: 4.872

3.  Association Between Process-Based Quality Indicators and Mortality for Patients With Substance Use Disorders.

Authors:  Susan M Paddock; Kimberly A Hepner; Teresa Hudson; Songthip Ounpraseuth; Amy M Schrader; Greer Sullivan; Katherine E Watkins
Journal:  J Stud Alcohol Drugs       Date:  2017-05       Impact factor: 2.582

4.  Racial Disparities in Health Care Utilization at the End of Life Among New Jersey Medicaid Beneficiaries With Advanced Cancer.

Authors:  Annie Yang; David Goldin; Jose Nova; Jyoti Malhotra; Joel C Cantor; Jennifer Tsui
Journal:  JCO Oncol Pract       Date:  2020-04-16

5.  Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999.

Authors:  David S Mandell; Jun Cao; Richard Ittenbach; Jennifer Pinto-Martin
Journal:  J Autism Dev Disord       Date:  2006-05

6.  Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data.

Authors:  Chad Tang; Xiudong Lei; Grace L Smith; Hubert Y Pan; Kenneth Hess; Aileen Chen; Karen E Hoffman; Brian F Chapin; Deborah A Kuban; Mitchell Anscher; Ya-Chen Tina Shih; Steven J Frank; Benjamin D Smith
Journal:  Pract Radiat Oncol       Date:  2020-04-13

7.  Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?

Authors:  Dejana Braithwaite; Weiwei Zhu; Rebecca A Hubbard; Ellen S O'Meara; Diana L Miglioretti; Berta Geller; Kim Dittus; Dan Moore; Karen J Wernli; Jeanne Mandelblatt; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2013-02-05       Impact factor: 13.506

8.  Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer.

Authors:  Michaela A Dinan; Yanhong Li; Yinghong Zhang; Suzanne B Stewart; Lesley H Curtis; Daniel J George; Shelby D Reed
Journal:  Clin Genitourin Cancer       Date:  2015-08-06       Impact factor: 2.872

9.  Adapting the Elixhauser comorbidity index for cancer patients.

Authors:  Hemalkumar B Mehta; Sneha D Sura; Deepak Adhikari; Clark R Andersen; Stephen B Williams; Anthony J Senagore; Yong-Fang Kuo; James S Goodwin
Journal:  Cancer       Date:  2018-02-01       Impact factor: 6.860

10.  Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.

Authors:  Beth M Beadle; Kai-Ping Liao; Sharon H Giordano; Adam S Garden; Katherine A Hutcheson; Stephen Y Lai; B Ashleigh Guadagnolo
Journal:  Cancer       Date:  2016-09-23       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.